This article tries to lay out these inter-sectional linkages through the means of recent advocacy initiatives against the unethical conduct of trials on marginalised communities along with the broader scope of regulation of the biomedical research industry in India. A special case can also be made for legal clinics for students seeking to explore the intersectionality between law and ethics in the field of biomedical research in India. This is particularly important given the dynamic pace and scope of the industry that creates complex legal and ethical issues, questions and controversies, which often seem to fall through the gaps.
BhaumikD.ChandiraM.ChiranjibB. (2010). Emerging trends of scope and opportunities clinical trials in India. International Journal of Pharmacy and Pharmaceutical Sciences, 2(1), 7–20.
2.
ChatterjeeP. (2008). Clinical trials in India: Ethical concerns. Bulletin of the World Health Organization, 86 (8). Retrieved from: http://www.who.int/bulletin/volumes/86/8/08-010808/en/index.html (accessed on 1 July 2011).
3.
Clinical Trial Registry of India. (2010). Retrieved from: http://ctri.nic.in/Clinicaltrials/login.php (accessed on 3 June 2011).
4.
DharA. (2010, 7April). Centre Halts HPV Vaccine Project. The Hindu. Available at (http://beta.thehindu.com/news/national/arti- cle391024.ece).
5.
GreeneW. (2007). The emergence of India’s pharmaceutical industry and implications for the US generic drug market. Office of Economics Working Paper, US International Trade Commission, Washington D.C., USA.
6.
MIMS (2010). Bhopal gas victims used as guinea pigs. Monthly Index of Medical Specialities– Editorial.
7.
MudurG. (2005). India plans to audit clinical trials. BMJ, 331(7524), 1044.
8.
PaliwalA. (2011). Ethics on trial. Down to Earth. Retrived from: http://www.downtoearth.org.in/content/ethics-trial (accessed on 2 July 2011).
9.
PandeyaR. (2010). Drug regulator seeks inquiry into Bhopal clinical trials. Live Mint. Retrieved from: http://www.livemint.com/2010/08/04215714/Drug-regulator-seeks-inquiry-i.html?atype=tp (accessed on 2 July 2011).
10.
PetrynaA. (2005). Ethical variability: Drug development and globalizing clinical trials. American Ethnologist, 32 (2), 183–197.
11.
RajanS.K. (2007). Biocapital: Indian clinical trials and surplus health. New Left Review.
12.
RNCOS. (2007). Booming clinical trials market in India. Retrieved from: http://www.rncos.com/Report/IM564.htm (accessed on 1 July 2011).
13.
Sama. (2011). National consultation on regulation of drug trials: A report. Delhi: Sama Resource Group for Women and Health.
14.
SarojiniN.SrinivasanS.MadhaviY.SrinivasanS.ShenoiA. (2010). The HPV Vaccine: Science, ethics and regulation. Economic and Political Weekly, 40 (48), 27–34.
15.
SarojiniN.ShenoiA.SrinivasanS.JesaniA. (2011). Undeniable violations and unidentifiable violators. Economic and Political Weekly, 46 (24), 17–19.
16.
SrinivasanS. (2009). Ethical concerns in clinical trials in India: An investigation. Mumbai: Centre for Studies in Ethics and Rights.
